Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.

Condition:   Urothelial Carcinoma Intervention:   Drug: Cabozantinib Sponsors:   Johannes Gutenberg University Mainz;   Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials